Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
Since the discovery of the hepatitis B virus (HBV) by Blumberg et al. in 1965, its genome, sequence, epidemiology, and hepatocarcinogenesis have been elucidated. Globally, hepatitis B virus (HBV) is still responsible for the majority of hepatocellular carcinoma (HCC). HCC is the sixth-most common ca...
Main Authors: | Joseph Yoo, Hie-Won Hann, Robert Coben, Mitchell Conn, Anthony J. DiMarino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-04-01
|
Series: | Diseases |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-9721/6/2/27 |
Similar Items
-
HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
by: Zijun Ge, et al.
Published: (2019-06-01) -
The function of HBx in HBV-induced hepatocellular carcinoma
by: Lu Zhaoliang
Published: (2018-04-01) -
Genomic and transcriptome profiling identified both human and HBV genetic variations and their interactions in Chinese hepatocellular carcinoma
by: Hua Dong, et al.
Published: (2015-12-01) -
Primary hepatocellular carcinoma in HBV infected patient - a case report
by: Patrycja Łanowy, et al.
Published: (2019-09-01) -
HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy
by: Yeh CN, et al.
Published: (2018-11-01)